These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 35037069)
21. Tacrolimus: a further update of its use in the management of organ transplantation. Scott LJ; McKeage K; Keam SJ; Plosker GL Drugs; 2003; 63(12):1247-97. PubMed ID: 12790696 [TBL] [Abstract][Full Text] [Related]
22. A randomised controlled trial of total immunosuppression withdrawal in stable liver transplant recipients. Assy N; Adams PC; Myers P; Simon V; Ghent CN Gut; 2007 Feb; 56(2):304-6. PubMed ID: 17303606 [No Abstract] [Full Text] [Related]
23. Immunosuppression with budesonide for liver transplant recipients with severe infections. Bhat M; Ghali P; Wong P; Marcus V; Michel R; Cantarovich M; Metrakos P; Deschenes M Liver Transpl; 2012 Feb; 18(2):262-3. PubMed ID: 22006869 [No Abstract] [Full Text] [Related]
24. Pretransplant Psychosocial Risk Factors May Not Predict Late Nonadherence and Graft Rejection in Adult Liver Transplant Recipients. Lieber SR; Helcer J; Leven E; Knight CS; Wlodarkiewicz C; Shenoy A; Shemesh E; Florman SS; Schiano TD; Annunziato RA Exp Clin Transplant; 2018 Oct; 16(5):533-540. PubMed ID: 28969524 [TBL] [Abstract][Full Text] [Related]
25. Medication level variability index predicts rejection, possibly due to nonadherence, in adult liver transplant recipients. Christina S; Annunziato RA; Schiano TD; Anand R; Vaidya S; Chuang K; Zack Y; Florman S; Shneider BL; Shemesh E Liver Transpl; 2014 Oct; 20(10):1168-77. PubMed ID: 24931127 [TBL] [Abstract][Full Text] [Related]
26. Current Practice in Immunosuppression in Pediatric Liver Transplantation. Vincenzi R; Fonseca EA; Roda KMO; Chapchap P; Neto JS Curr Pharm Des; 2020; 26(28):3402-3405. PubMed ID: 32534559 [TBL] [Abstract][Full Text] [Related]
27. Use of antilymphocyte induction therapy in liver transplantation. Wall WJ Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S64-70. PubMed ID: 10431019 [TBL] [Abstract][Full Text] [Related]
28. From immunosuppression to tolerance. Adams DH; Sanchez-Fueyo A; Samuel D J Hepatol; 2015 Apr; 62(1 Suppl):S170-85. PubMed ID: 25920086 [TBL] [Abstract][Full Text] [Related]
29. Immunosuppressive Drug Levels in Liver Transplant Recipients: Impact in Decision Making. Kourkoumpetis T; Levitsky J Semin Liver Dis; 2019 Nov; 39(4):414-421. PubMed ID: 31041787 [TBL] [Abstract][Full Text] [Related]
30. Antibody-mediated rejection in liver transplant recipients: Some questions, some answers. De Martin E; McCaughan GW Liver Transpl; 2023 Dec; 29(12):1260-1261. PubMed ID: 37548557 [No Abstract] [Full Text] [Related]
34. Need for optimized immunosuppression in elderly kidney transplant recipients. Lehner LJ; Staeck O; Halleck F; Liefeldt L; Bamoulid J; Budde K Transplant Rev (Orlando); 2015 Oct; 29(4):237-9. PubMed ID: 26411381 [TBL] [Abstract][Full Text] [Related]
35. Long-term immunosuppression after liver transplantation: are steroids necessary? Padbury RT; Gunson BK; Dousset B; Hubscher SG; Mayer AD; Buckels JA; Neuberger JM; Elias E; McMaster P Transpl Int; 1992; 5 Suppl 1():S470-2. PubMed ID: 14621849 [TBL] [Abstract][Full Text] [Related]
36. Effects of different immunosuppressive regimens on regulatory T-cells in noninflamed colon of liver transplant recipients. Verdonk RC; Haagsma EB; Jonker MR; Bok LI; Zandvoort JH; Kleibeuker JH; Faber KN; Dijkstra G Inflamm Bowel Dis; 2007 Jun; 13(6):703-9. PubMed ID: 17230494 [TBL] [Abstract][Full Text] [Related]
37. Exploring predicted indirectly recognizable HLA epitopes (PIRCHE-II) in liver transplant recipients on calcineurin inhibitor-free maintenance immunosuppression. A retrospective single center study. Meszaros M; Niemann M; Ursic-Bedoya J; Faure S; Meunier L; Rivière B; Costes-Martineau V; Thevenin C; Pageaux GP Transpl Immunol; 2020 Apr; 59():101272. PubMed ID: 32061667 [TBL] [Abstract][Full Text] [Related]
38. Immunosuppression Has Long-Lasting Effects on Circulating Follicular Regulatory T Cells in Kidney Transplant Recipients. Niu Q; Mendoza Rojas A; Dieterich M; Roelen DL; Clahsen-van Groningen MC; Wang L; van Gelder T; Hesselink DA; van Besouw NM; Baan CC Front Immunol; 2020; 11():1972. PubMed ID: 32983131 [No Abstract] [Full Text] [Related]
39. Manzia TM; Angelico R; Gazia C; Lenci I; Milana M; Ademoyero OT; Pedini D; Toti L; Spada M; Tisone G; Baiocchi L World J Gastroenterol; 2019 Sep; 25(35):5356-5375. PubMed ID: 31558879 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of rejection, infection, and malignancy outcomes in elderly liver transplant recipients receiving a similar level of immunosuppression compared to a younger group. Almalki B; Kane C; Cunningham K; D'Agostino C; Novak A; Kapugi M; Ladner D; Schulte J Transpl Immunol; 2021 Dec; 69():101485. PubMed ID: 34673200 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]